2417P De-escalation of therapy with androgen receptor pathway inhibitors or docetaxel by using PSMA PET/CT in metastatic castration-resistant prostate cancer patients: Study results from a Dutch cohort

K.J.M. van der Velden; S. van Mossel; F. Kleiburg; D. Bosch; L-F. de Geus-Oei; T. Van Der Hulle; M. Kuppen; C. Uyl-de Groot; I.M. van Oort; L. Heijmen

doi:10.1016/j.annonc.2025.08.3033

2417P De-escalation of therapy with androgen receptor pathway inhibitors or docetaxel by using PSMA PET/CT in metastatic castration-resistant prostate cancer patients: Study results from a Dutch cohort

K.J.M. van der Velden
, S. van Mossel
, F. Kleiburg
, D. Bosch
, L-F. de Geus-Oei
, T. Van Der Hulle
, M. Kuppen
, C. Uyl-de Groot
, I.M. van Oort
, L. Heijmen

Biomedical Photonic Imaging

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	S1228
Number of pages	1
Journal	Annals of oncology
Volume	36
Issue number	Suppl. 2
DOIs	https://doi.org/10.1016/j.annonc.2025.08.3033
Publication status	Published - Sept 2025
Event	ESMO Congress 2025 - Messe Berlin, Berlin, Germany Duration: 17 Oct 2025 → 21 Oct 2025 https://www.esmo.org/meeting-calendar/esmo-congress-2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.annonc.2025.08.3033

Cite this

van der Velden, K. J. M., van Mossel, S., Kleiburg, F., Bosch, D., Geus-Oei, L.-F. D., Van Der Hulle, T., Kuppen, M., Uyl-de Groot, C., van Oort, I. M., & Heijmen, L. (2025). 2417P De-escalation of therapy with androgen receptor pathway inhibitors or docetaxel by using PSMA PET/CT in metastatic castration-resistant prostate cancer patients: Study results from a Dutch cohort. Annals of oncology, 36(Suppl. 2), S1228. https://doi.org/10.1016/j.annonc.2025.08.3033

@article{cf6c8266354b4a56aff176fa70ee6702,

title = "2417P De-escalation of therapy with androgen receptor pathway inhibitors or docetaxel by using PSMA PET/CT in metastatic castration-resistant prostate cancer patients: Study results from a Dutch cohort",

author = "\{van der Velden\}, K.J.M. and \{van Mossel\}, S. and F. Kleiburg and D. Bosch and Geus-Oei, \{L-F. de\} and \{Van Der Hulle\}, T. and M. Kuppen and \{Uyl-de Groot\}, C. and \{van Oort\}, I.M. and L. Heijmen",

year = "2025",

month = sep,

doi = "10.1016/j.annonc.2025.08.3033",

language = "English",

volume = "36",

pages = "S1228",

journal = "Annals of oncology",

issn = "0923-7534",

publisher = "Elsevier",

number = "Suppl. 2",

note = "ESMO Congress 2025, ESMO 2025 ; Conference date: 17-10-2025 Through 21-10-2025",

url = "https://www.esmo.org/meeting-calendar/esmo-congress-2025",

}

van der Velden, KJM, van Mossel, S, Kleiburg, F, Bosch, D, Geus-Oei, L-FD, Van Der Hulle, T, Kuppen, M, Uyl-de Groot, C, van Oort, IM & Heijmen, L 2025, '2417P De-escalation of therapy with androgen receptor pathway inhibitors or docetaxel by using PSMA PET/CT in metastatic castration-resistant prostate cancer patients: Study results from a Dutch cohort', Annals of oncology, vol. 36, no. Suppl. 2, pp. S1228. https://doi.org/10.1016/j.annonc.2025.08.3033

2417P De-escalation of therapy with androgen receptor pathway inhibitors or docetaxel by using PSMA PET/CT in metastatic castration-resistant prostate cancer patients: Study results from a Dutch cohort. / van der Velden, K.J.M.; van Mossel, S.; Kleiburg, F. et al.
In: Annals of oncology, Vol. 36, No. Suppl. 2, 09.2025, p. S1228.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - 2417P De-escalation of therapy with androgen receptor pathway inhibitors or docetaxel by using PSMA PET/CT in metastatic castration-resistant prostate cancer patients

T2 - ESMO Congress 2025

AU - van der Velden, K.J.M.

AU - van Mossel, S.

AU - Kleiburg, F.

AU - Bosch, D.

AU - Geus-Oei, L-F. de

AU - Van Der Hulle, T.

AU - Kuppen, M.

AU - Uyl-de Groot, C.

AU - van Oort, I.M.

AU - Heijmen, L.

PY - 2025/9

Y1 - 2025/9

U2 - 10.1016/j.annonc.2025.08.3033

DO - 10.1016/j.annonc.2025.08.3033

M3 - Meeting Abstract

SN - 0923-7534

VL - 36

SP - S1228

JO - Annals of oncology

JF - Annals of oncology

IS - Suppl. 2

Y2 - 17 October 2025 through 21 October 2025

ER -

van der Velden KJM, van Mossel S, Kleiburg F, Bosch D, Geus-Oei LFD, Van Der Hulle T et al. 2417P De-escalation of therapy with androgen receptor pathway inhibitors or docetaxel by using PSMA PET/CT in metastatic castration-resistant prostate cancer patients: Study results from a Dutch cohort. Annals of oncology. 2025 Sept;36(Suppl. 2):S1228. doi: 10.1016/j.annonc.2025.08.3033